Tg Therapeutics Inc (TGTX)

SG&A Expense Growth

-6.90%

Quarterly · Period ending:

TGTX logo

TGTX SG&A Expense Growth

Latest reported-6.90%
TGTX Quarterly SG&A Growth (QoQ) (0.00% → -6.90%)
High-resolution chart · PNG

TGTX sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
69.7633%
67.1293%
-25.0788%
-82.5279%
110.8217%
88.0622%
100%
33.3333%
-25%
33.3333%
-62.5%
-20%
66.6667%
-25%
33.3333%
-14.2857%
0%
-12.5%
-11.1111%
80%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.